Secondary Outcomes
SECONDARY
With respect to secondary outcomes, the proportion of patients with a favorable functional outcome (mRS score of 0-2) in the GDLM group was 83.8% compared with 69.5% in the placebo group (risk difference, 14.35%; 95% CI, 11.56%-17.12%; OR, 2.28; 95% CI, 1.93-2.68; RR, 1.21; 95% CI, 1.16-1.25; 